Estados financieros detallados de Stereotaxis, Inc. (STXS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Stereotaxis, Inc. registró ingresos de $32.4M en el último ejercicio fiscal, con un CAGR de 5 años del 4.0%.
Márgenes de los últimos 12 meses: margen bruto 55.6%, margen operativo -73.0%, margen neto -74.2%.
Al precio actual de $1.32, STXS presenta beneficios negativos (P/E no significativo) y un ROE del -132.62%. La capitalización bursátil es de $129M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $32.2M | $31.1M | $29.3M | $28.9M | $26.6M | $35.0M | $28.1M | $26.8M | $26.9M | $32.4M |
| Coste de Ventas | $7.5M | $10.8M | $5.7M | $6.1M | $7.7M | $11.8M | $9.7M | $11.9M | $12.3M | $15.3M |
| Beneficio Bruto | $24.6M | $20.4M | $23.6M | $22.8M | $19.0M | $23.2M | $18.5M | $14.9M | $14.6M | $17.1M |
| I+D | $5.5M | $4.8M | $8.2M | $9.0M | $8.1M | $10.2M | $10.6M | $10.3M | $9.8M | $9.4M |
| Generales y Administrativos | $25.6M | $21.5M | $17.9M | $18.6M | $17.5M | $25.9M | $26.7M | $26.4M | $29.6M | $30.3M |
| Gastos Operativos | $31.1M | $26.3M | $26.1M | $27.6M | $25.7M | $36.1M | $37.2M | $36.7M | $39.3M | $39.2M |
| Beneficio Operativo | -$6.4M | -$5.9M | -$2.5M | -$4.8M | -$6.7M | -$12.9M | -$18.8M | -$21.8M | -$24.7M | -$22.1M |
| EBITDA | -$5.9M | -$5.1M | -$1.8M | -$4.7M | -$6.6M | -$10.6M | -$17.9M | -$20.1M | -$23.1M | -$20.1M |
| Gastos por Intereses | $2.5M | $179844 | $16566 | 0 | 0 | $10071 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| BPA | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| BPA Diluido | $-0.24 | $-0.26 | $0.00 | $-0.07 | $-0.11 | $-0.16 | $-0.26 | $-0.27 | $-0.30 | $-0.25 |
| Acciones en Circulación (Diluidas) | $21.8M | $22.6M | $52.1M | $63.1M | $72.7M | $75.6M | $76.1M | $80.7M | $85.2M | $91.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $7.5M | $8.6M | $6.3M | $7.7M |
| Beneficio Bruto | $4.1M | $4.3M | $3.8M | $4.5M |
| Beneficio Operativo | -$6.6M | -$5.6M | -$5.2M | -$4.6M |
| EBITDA | -$6.1M | -$5.1M | -$5.5M | -$4.5M |
| Beneficio Neto | -$6.5M | -$5.5M | -$5.9M | -$4.5M |
| BPA | $-0.07 | $-0.06 | $-0.06 | $-0.05 |
| BPA Diluido | $-0.07 | $-0.06 | $-0.06 | $-0.05 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $8.5M | $3.7M | $10.8M | $30.2M | $43.9M | $38.7M | $8.6M | $19.8M | $12.2M | $13.4M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $19.8M | 0 | 0 | 0 |
| Cuentas por Cobrar | $4.7M | $4.3M | $5.0M | $5.3M | $3.5M | $5.4M | $5.1M | $3.8M | $3.8M | $10.2M |
| Inventario | $5.4M | $1.1M | $1.2M | $1.8M | $3.3M | $4.4M | $7.9M | $8.4M | $8.3M | $9.6M |
| Activos Corrientes | $19.4M | $9.9M | $18.0M | $38.8M | $52.7M | $51.4M | $43.2M | $33.3M | $26.4M | $33.8M |
| Inmovilizado Material | $1.1M | $592688 | $343693 | $4.5M | $2.4M | $8.4M | $9.2M | $8.3M | $9.1M | $7.9M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.8M | $3.8M |
| Activos Intangibles | $436569 | $159470 | 0 | 0 | 0 | 0 | 0 | 0 | $7.4M | $6.4M |
| Activos Totales | $21.0M | $10.7M | $18.5M | $43.6M | $55.5M | $61.0M | $53.4M | $41.9M | $46.7M | $52.3M |
| Cuentas por Pagar | $2.6M | $1.7M | $1.7M | $2.1M | $1.6M | $4.2M | $3.3M | $3.2M | $5.7M | $4.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $35.7M | $30.1M | $10.2M | $12.2M | $13.6M | $13.3M | $14.3M | $13.2M | $21.6M | $22.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $973252 | 0 | 0 | 0 | 0 | $4.8M |
| Pasivos Totales | $36.5M | $31.3M | $11.2M | $15.1M | $15.2M | $21.6M | $21.5M | $20.0M | $35.3M | $33.5M |
| Reservas | -$471.2M | -$477.1M | -$476.7M | -$481.3M | -$488.0M | -$498.7M | -$517.0M | -$537.7M | -$561.7M | -$583.4M |
| Patrimonio Neto | -$15.5M | -$20.6M | $7.3M | $28.5M | $40.2M | $39.4M | $31.9M | $21.9M | $11.4M | $18.7M |
| Deuda Total | 0 | 0 | 0 | $4.3M | $4.4M | $6.1M | $5.9M | $5.5M | $6.0M | $5.4M |
| Deuda Neta | -$8.5M | -$3.7M | -$10.8M | -$25.8M | -$39.5M | -$32.6M | -$22.6M | -$14.3M | -$6.2M | -$8.0M |
| Capital Circulante | -$16.2M | -$20.3M | $7.8M | $26.7M | $39.1M | $38.1M | $29.0M | $20.0M | $4.8M | $11.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $10.5M | $13.4M | $14.6M | $10.5M |
| Activos Totales | $45.6M | $52.3M | $54.0M | $55.6M |
| Pasivos Totales | $34.1M | $33.5M | $34.4M | $38.1M |
| Patrimonio Neto | $11.5M | $18.7M | $19.6M | $17.5M |
| Deuda Total | $5.6M | $5.4M | $5.3M | $5.2M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$5.3M | -$5.9M | $116756 | -$4.6M | -$6.6M | -$10.7M | -$18.3M | -$20.7M | -$24.0M | -$21.6M |
| Amortizaciones | $566931 | $753682 | $579017 | $122736 | $126211 | $106000 | $429000 | $595000 | $969000 | $1.6M |
| Compensación en Acciones | $1.4M | $768682 | $560973 | $1.3M | $3.2M | $9.4M | $10.6M | $10.6M | $10.3M | $9.9M |
| Cambio en Capital Circulante | -$259161 | -$4.2M | -$1.7M | -$3.8M | -$2.5M | $135000 | -$1.1M | $612000 | $2.5M | -$5.6M |
| Flujo de Caja Operativo | -$6.6M | -$4.7M | -$2.5M | -$4.6M | -$3.5M | -$2.9M | -$8.4M | -$9.1M | -$8.5M | -$13.7M |
| Inversiones (CapEx) | -$410184 | -$81577 | -$265482 | -$29486 | -$70896 | -$1.4M | -$2.4M | -$366000 | -$34000 | -$93000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $108000 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.0M | -$4.8M | -$2.8M | -$4.6M | -$3.6M | -$4.3M | -$10.8M | -$9.5M | -$8.5M | -$13.8M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.2M | -$4.0M | -$3.4M | -$3.7M |
| Inversiones (CapEx) | 0 | -$70000 | -$79000 | -$64000 |
| Flujo de Caja Libre | -$4.2M | -$4.0M | -$3.5M | -$3.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.5M | $2.4M | $2.1M | $1.6M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | -3.2% | -5.8% | -1.5% | -7.9% | +31.5% | -19.6% | -4.9% | +0.5% | +20.3% |
| Crecimiento Beneficio Neto (anual) | | -11.4% | +102.0% | -4032.4% | -44.8% | -61.2% | -70.7% | -13.2% | -16.1% | +10.0% |
| Crecimiento BPA (anual) | | -8.3% | +100.8% | -3150.0% | -63.9% | -45.5% | -62.5% | -3.8% | -11.1% | +16.7% |
| Cambio en Acciones (anual) | | +3.7% | +130.3% | +21.1% | +15.4% | +3.9% | +0.7% | +6.1% | +5.6% | +6.8% |
| Crecimiento FCF (anual) | | +31.8% | +40.9% | -65.2% | +22.9% | -21.2% | -148.5% | +11.9% | +10.2% | -61.5% |
| Margen Bruto | 76.6% | 65.5% | 80.5% | 78.8% | 71.2% | 66.3% | 65.6% | 55.5% | 54.2% | 52.7% |
| Margen Operativo | -20.0% | -19.0% | -8.4% | -16.7% | -25.2% | -36.8% | -66.7% | -81.6% | -91.9% | -68.3% |
| Margen EBITDA | -18.2% | -16.3% | -6.1% | -16.3% | -24.7% | -30.3% | -63.5% | -75.1% | -85.7% | -62.0% |
| Margen Neto | -16.4% | -18.9% | 0.4% | -15.9% | -25.0% | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |
| Margen FCF | -21.7% | -15.3% | -9.6% | -16.1% | -13.5% | -12.4% | -38.3% | -35.5% | -31.7% | -42.6% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.32 | $-0.21 | $-0.05 | $-0.07 | $-0.05 | $-0.06 | $-0.14 | $-0.12 | $-0.10 | $-0.15 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $21.8M | $22.6M | $52.1M | $63.1M | $72.7M | $75.6M | $76.1M | $80.7M | $85.2M | $91.0M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -132.62% |
| Rentabilidad sobre capital invertido | -74.49% |
| Rentabilidad sobre activos | -40.16% |
| Margen bruto | 55.57% |
| Margen operativo | -73.02% |
| Margen neto | -74.24% |
Salud financiera
| Deuda / Patrimonio | 0.30 |
| Ratio corriente | 1.42 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2.71 | -3.08 | 491.36 | -78.84 | -46.27 | -38.75 | -7.96 | -6.48 | -7.60 | -9.20 |
| P/VC | -0.91 | -0.88 | 7.74 | 11.69 | 9.20 | 11.88 | 4.93 | 6.44 | 16.99 | 11.17 |
| P/V | 0.44 | 0.58 | 1.92 | 11.54 | 13.90 | 13.38 | 5.59 | 5.28 | 7.22 | 6.46 |
| Margen Bruto | 76.6% | 65.5% | 80.5% | 78.8% | 71.2% | 66.3% | 65.6% | 55.5% | 54.2% | 52.7% |
| Margen Operativo | -20.0% | -19.0% | -8.4% | -16.7% | -25.2% | -36.8% | -66.7% | -81.6% | -91.9% | -68.3% |
| Margen Neto | -16.4% | -18.9% | 0.4% | -15.9% | -25.0% | -30.6% | -65.0% | -77.4% | -89.3% | -66.8% |